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This paper describes the clinical use of the dose verification of multileaf collimator (MLC)-based 
CyberKnife plans by combining the Octavius 1000SRS detector and water-equivalent RW3 slab 
phantom. The slab phantom consists of 14 plates, each with a thickness of 10 mm. One plate was 
modified to support tracking by inserting 14 custom-made fiducials on surface holes positioned at 
the outer region of 10×10 cm2. The fiducial-inserted plate was placed on the 1000SRS detector 
and three plates were additionally stacked up to build the reference depth. Below the detector, 10 
plates were placed to avoid longer delivery times caused by proximity detection program alerts. 
The cross-calibration factor prior to phantom delivery was obtained by performing with 200 
monitor units (MU) on the field size of 95×92.5 mm2. After irradiation, the measured dose 
distribution of the coronal plane was compared with the dose distribution calculated by the 
MultiPlan treatment planning system. The results were assessed by comparing the absolute dose 
at the center point of 1000SRS and the 3-D Gamma (g) index using 220 patient-specific quality 
assurance (QA). The discrepancy between measured and calculated doses at the center point of 
1000SRS detector ranged from −3.9% to 8.2%. In the dosimetric comparison using 3-D g-function 
(3%/3 mm criteria), the mean passing rates with g-parameter ≤ 1 were 97.4%±2.4%. The 
combination of the 1000SRS detector and RW3 slab phantom can be utilized for dosimetry 
validation of patient-specific QA in the CyberKnife MLC system, which made it possible to 
measure absolute dose distributions regardless of tracking mode.
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Introduction
The CyberKnife (Accuray Inc., Sunnyvale, CA, USA) sys-
tem is designed for robotic radiosurgery and stereotactic 
body radiotherapy. Its intrafraction motion tracking abili-
ties enable delivery of high doses of radiation in only a 
few fractions.1) Non-coplanar beams with sub-millimeter 
accuracy provide a highly conformal dose distribution. A 
newly released M6 model, 5th generation CyberKnife sys-
tem, makes it possible to use multileaf collimator (MLC).2) 
In addition to conventional benefits of CyberKnife, the use 
of MLC can be expected to create fields that match the tu-
mor shape closely and spare critical organs, providing bet-
ter dose distributions with an advantage in reducing beam 
delivery time.3,4) The good candidates for the MLC system 
can be thus considered as the treatment of large targets or 
targets near critical organs. However, the new MLC system 
has all the potential issues like other MLC deliveries that 
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small changes in field size, dose rate, and MLC speed for 
each segment can significantly affect the dose accuracy. A 
few fractions indicate fewer chances to catch errors during 
treatment. In addition, Task Group (TG) 135 recommends 
that pretreatment delivery quality assurance (DQA) should 
be performed for every patient on a newly installed ma-
chine until the treatment team gets a good assessment.5) 
At this point, it is essential to conduct at the same level of 
DQA that one would perform for linear accelerator IMRT 
or Tomotherapy patients,6) until we have valuable data to 
judge the level of risk.
In this study, we focused on the clinical use of a 2D-array 
ion chamber with fiducial-inserted solid water phantom 
applicable to MLC-based CyberKnife system. The Octavi-
ous 1000SRS detector (PTW, Freiburg, Germany) as 2D-
array ion chamber was used in linear accelerator for dosi-
metric measurement.7) In the treatment planning system 
for CyberKnife, the presence of fiducial is important to 
generate patient-specific QA plan because the coincidence 
of tracking method is only compatible to make QA plans 
except the fiducial method. We designed the customized 
14 fiducial-inserted slab phantom to support fiducial track-
ing with the Octavius 1000SRS detector. To our knowledge, 
this is the first study using high sensitive 2D ion chamber 
array detector that has evaluated the clinical application 
of measurement-based patient-specific QA in the new Cy-
berKnife MLC system.
Materials and Methods
1. Patient-specific QA phantom
1) Octavius 1000SRS detector 
The characteristics of Octavius 1000SRS were examined 
by Markovlc el al.7). The detector has a high resolution re-
gion, 2.5 mm, in the size of 5.5×5.5 cm2 and a lower resolu-
tion region, 5 mm, in outer field size. And the maximum 
field size of detector is 11×11 cm2. The 2D array consists of 
977 liquid-filled ionization chambers. The dimension of 
each detector is 2.3 mm×2.3 mm×0.5 mm. The reference 
point of measurement is positioned at 9.0 mm below the 
surface of the array. The Octavius detector is controlled by 
the VeriSoft software (PTW, Freiburg, Germany), which is 
used during measurement acquisition and analysis of the 
measurements. The software provides the evaluation tools 
such as profile comparison, planar isodose overlay, and 
gamma index calculation.
2) Design of fiducial-inserted RW3 Solid Water
Because fiducial tracking is compatible regardless of 
tracking modes used in the patient plans, we designed 
the customized fiducial-inserted RW3 Solid Water (PTW 
Freiburg, Freiburg, Germany). The physical density of RW3 
is 1.045 g/cm3, the effective material parameter (Z/Ar)eff is 
0.536 and the electron density is higher than that of water 
by a factor of 1.012. 14 white golds as fiducials were in-
serted on the surface of RW3 as shown in Fig. 1. Among 14 
fiducials, more than one fiducial can be required for track-
ing in the target zone during beam delivery. Previously-
a b
Target zone
X-ray imager1 X-ray imager2
Fig. 1. The position of fiducial-in-
serted RW3 slab in patient-specific 
QA phantom: (a) Target zone over-
lapped by two x-ray imagers and (b) 
RW3 plate including 14 custom-made 
fiducials.
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used fiducial plate has four fiducials in a plate. It could not 
be used any more left or right shifted cases because the 
target zone is fixed at machine center. 
3) Patient-specific QA phantom setup
14 RW3 slabs were set up to measure the dose distribu-
tion from coronal plan. The thickness of each plate is 10 
mm. Only one plate was modified to support tracking by 
inserting 14 customized fiducials on surface hole where 
the fiducials are orthogonally positioned on outer region 
of array. As shown in Fig. 2, the modified plate was placed 
on the Octavius 1000SRS detector. 10 slabs below 1000SRS 
detector were placed to avoid longer delivery times caused 
by proximity detection program alerts. Three slabs were 
stacked up on the modified plate to build the reference 
depth.
2. Generation of QA template plan
MultiPlan 5.1.2 treatment planning system (Accuray Inc., 
Sunnyvale, CA, USA), used with Cyberknife MLC system, 
provides the finite size pencil beam (FSPB) algorithm for 
the final dose calculation. Five tracking methods8,9) were 
supported by the MultiPlan: Fiducial, Synchrony, Xsight 
Lung, Xsight Spine and 6D Skull. Most methods use the 
same tracking method for both patient plan and QA tem-
plate plan as shown in Table 1. However, when QA tem-
plate plan is created using fiducial tracking, it is compatible 
to all of tracking method for patient plans. In the target 
zone, the fiducial could be the  identified by fiducial finder 
in MultiPlan system (Fig. 3a). 
3. DQA plan and delivery
DQA plan procedure began with selecting the volume 
of interest (VOI) (Fig. 3b) at the patient plan and then 
exact alignment of the VOI at the QA template plan was 
performed. Next, the dose calculation for DQA plan was 
performed by using the same patient plan data such as 
beam data, system data, path set, anatomy center, and ref-
erence point. After then, rescale of monitor unit (MU) was 
required for delivery time reduction. Finally the calculated 
3D dose distributions were exported from MultiPlan (Fig. 
4). The cross-calibration factor prior to phantom delivery 
was obtained by performing with 200 MU on the field size 
of 95×92.5 mm2. 
Fig. 2. Patient-specific QA phantom including fiducial-inserted 
solid water phantom and Octavius 1000SRS detector.
Table 1. Tracking mode compatibility between patient plan and QA template plan.
Tracking method
QA template plan
Fiducial
QA template plan
Synchrony
QA template plan
Xsight Lung
QA template plan
Xsight Spine
QA template plan
6D Skull
Patient Plan 
Fiducial
Compatible
Patient Plan 
Synchrony
Compatible
(with warning)
Compatible
Patient Plan 
Xsight Lung
Compatible
(with warning)
Compatible
Patient Plan 
Xsight Spine
Compatible
(with warning)
Compatible
Patient Plan 
6D Skull
Compatible
(with warning)
Compatible
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4. Analysis of DQA plan and delivery
We analyzed 220 intracranial and extracranial cases us-
ing MLC. The number of cases using different tracking 
methods is shown in Table 2. Among five tracking methods, 
the Xsight Spine tracking method was mostly used in this 
study (Table 2). The measured dose distribution of coronal 
plane (2-D array after DQA plan delivery) was compared 
with the 3D dose distribution calculated by MultiPlan for 
cross-validation (Fig. 5). We evaluated point dose differ-
ence (%) at the center of Octavius 1000SRS and 3D gamma 
(g) index agreement. The g function criteria is based on the 
distance-to-agreement of 3 mm and the local dose differ-
ence of 3%.10)
Results
The overall point dose difference between measured 
and calculated doses ranged from -3.9% and 8.2% in Fig. 
6a. The mean point dose difference was 2.3%±2.3%. As 
shown in Fig. 6b, the mean passing rates with g≤1 were 
97.4%±2.4% in coronal plane. The lowest and highest 
gamma agreements were 90% and 100%, respectively. Also, 
the difference of point dose and gamma passing ratio was 
analyzed according to the tracking method (Table 3). For 
representative partial breast irradiation (PBI) patients with 
surgical clips, fiducial tracking was used. In this tracking 
method, the difference of point dose and gamma passing 
a b
Fig. 3. QA template plan: (a) Fiducial 
iden tifi cations in fiducial-inserted 
RW3 plate and (b) a volume of inter-
est representing ion chamber array.
If max dose is more than
1,000 cGy
Scale factor
Max dose check
Calculated isodose line
2
3
1
Fig. 4.  Procedures to export the 
cal culated 3D dose distribution in 
MultiPlan TPS.
Table 2. The number of cases used for patient-specific QA.
Tracking method Number of case
Fiducial 10
Synchrony 4
Xsight Lung 2
Xsight Spine 196
6D Skull 8
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ratio was 4.24%±2.27% and 97.05%±2.77%, respectively. 
For PBI or liver patients with synchrony tracking, the dif-
ference of point dose and gamma passing ratio showed 
0.84%±2.30% and 98.40%±0.83%. For lung treatment with 
high fractional dose (over 1500 cGy) with synchrony, Xsight 
Lung tracking was performed on the patient plan. The dif-
ference of point dose and gamma passing ratio showed 
1.34%±0.18% and 98.95%±1.06%. For C-spine or T-spine 
treatment, Xsight Spine tracking was used dominantly, 
which showed 2.30%±2.35% and 98.20%±2.47% for the dif-
ference of point dose and gamma passing ratio. For brain 
treatment, 6D Skull tracking was selected. Using this track-
ing, the difference of point dose and gamma passing ratio 
showed 2.68%±1.82% and 97.70%±1.96%.
Discussion
The current work focused on the MLC-based CyberKnife 
system. We performed the dose calculations with FSPB al-
gorithm, which is available in the MultiPlan for MLC-based 
CyberKnife system. Additionally, the results of this work 
can be extended to the cone-based CyberKnife treatment 
using ray tracing or Monte Carlo algorithms in MultiPlan 
system. 
There are other dosimetry tools that have the potential 
for CyberKnife delivery measurements.11-13) 2D film dosim-
etry offers superior spatial resolution for small field mea-
surements, but the resulting dose distributions are sensi-
Table 3. The Results for patient-specific QA.
Tracking  
method
Point dose  
difference (%)
Gamma passing  
ratio (%)
Fiducial 4.24±2.27 97.05±2.77
Synchrony 0.84±2.30 98.40±0.83
Xsight Lung 1.34±0.18 98.95±1.06
Xsight Spine 2.30±2.35 98.20±2.47
6D Skull 2.68±1.82 97.70±1.96
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Fig. 6. Quantitative comparisons using 220 patient specific QA plans: (a) point dose difference and (b) gamma agreement.
a b
Measured planar doseCalculated 3D dose distribution
Fig. 5. Comparison between mea-
sured planar dose and calculated 
3D dose distributions: (a) calculated 
point dose at the center of Octavius 
1000SRS detector and (b) measured 
planar dose distribution in Verisoft.
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tive to the handling method. Various electronic measuring 
devices are thus considered because they are capable for 
time-resolved analysis despite the limited spatial resolu-
tion. Compared with the electronic dosimetry devices such 
as MatriXX and ArcCHECK,12) the Octavius 1000SRS detec-
tor has a great advantage in cases involving the measure-
ment of the high resolution dose distributions especially in 
high dose gradient regions because the spacing between 
ion chambers is 2.5 mm in the central area (the field size 
of 5.5×5.5 cm2. In addition, the workload can be reduced 
since dose distributions are acquired, shown, and can be 
processed at once. The acquisition software, VeriSoft, can 
provide the graphical environment for the comparison and 
evaluation of the dose distributions. Also, the measured 
data can be saved in different formats for the analysis. For 
the limitation of detector size (2.3 mm×2.3 mm×0.5 mm) 
of Octavius 1000 SRS, we considered the selection of the 
tumor size of patients which is larger than 1 cm. When we 
had the case of smaller than 1 cm, we used Stereotactic 
Dose Verification Phantom (Standard Imaging, WI, USA) 
with Exradin A16 microchamber (Standard Imaging, WI, 
USA) and customized Gafchromic EBT3 film (Ashland ISP 
Advanced Materials, NJ, USA).
The CyberKnife system has a predefined safety zone 
around the patient based on the patient’s size. When we 
perform the patient-specific QA for a patient with the brain 
tumor, special attention is required to avoid the collision 
between the patient-specific QA phantom including Oc-
tavius 1000SRS detector and the moving robot arm due to 
the narrow patient safety zone.
Conclusion
We have demonstrated that the Octavius 1000SRS detec-
tor with fiducial-inserted RW3 slab phantom can be con-
sidered as a new dosimetric tool for robotic radiotherapy 
delivery QA. This combination made it reliable to measure 
absolute dose distributions regardless of tracking mode. It 
simultaneously achieved an accurate dosimetry validation 
of the noncoplanar delivery pattern.
Acknowledgements
This research was supported by Radiation Technology 
R&D program through the National Research Foundation 
of Korea funded by the Ministry of Science, ICT & Future 
Planning (NRF-2017M2A2A6A01070330) and by Basic Sci-
ence Research Program through the National Research 
Foundation of Korea funded by the Ministry of Education 
(NRF-2015R1D1A1A01056850). 
Conflicts of Interest
The authors have nothing to disclose.
Availability of Data and Materials
All relevant data are within the paper and its Supporting 
Information files.
References
1. Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic 
high dose fraction radiation therapy of extracranial tu-
mors using an accelerator. Clinical experience of the first 
thirty-one patients. Acta Oncol. 1995;34(6):861-70.
2. Yoon J, Park K, Kim JS, Kim YB, Lee H. Acceptance Test-
ing and Commissioning of Robotic Intensity-Modulated 
Radiation Therapy M6 System Equipped with InCiseTM 2 
Multileaf Collimator. Prog Med Phys. 2018;29(1):8-15.
3. Murai T, Hattori Y, Sugie C, Iwata H, Iwabuchi M, Shib-
amoto Y. Comparison of multileaf collimator and conven-
tional circular collimator systems in Cyberknife stereotac-
tic radiotherapy. J Radiat Res. 2017;58(5):693-700.
4. Mcguinness CM, Gottschalk AR, Lessard E, et al. In-
vestigating the clinical advantages of a robotic linac 
equipped with a multileaf collimator in the treatment of 
brain and prostate cancer patients. J Appl Clin Med Phys. 
2015;16(5):284-95.
5. Dieterich S, Cavedon C, Chuang CF, et al. Report of AAPM 
TG 135: quality assurance for robotic radiosurgery. Med 
Phys. 2011;38(6):2914-36.
6. Chong NS, Lee JJS, Kung WH, et al. Patient delivery quality 
assurance for linac-based IMRT and helical tomotherapy 
Progress in Medical Physics   Vol. 29, No. 2, June 2018 65
www.ksmp.or.kr
using solid state detectors. Radiat Meas. 2011;46(12):1993-
95.
7. Markovic M, Stathakis S, Mavroidis P, Jurkovic IA, Papan-
ikolaou N. Characterization of a two-dimensional liquid-
filled ion chamber detector array used for verification of 
the treatments in radiotherapy. Med Phys. 2014;41(5).
8. Seppenwoolde Y, Berbeco RI, Nishioka S, Shirato H, Heij-
men B. Accuracy of tumor motion compensation algo-
rithm from a robotic respiratory tracking system: A simu-
lation study. Med Phys. 2007;34(7):2774-84.
9. Pepin EW, Wu H, Zhang Y, Lord B. Correlation and predic-
tion uncertainties in the cyberknife synchrony respiratory 
tracking system. Med Phys. 2011;38(7):4036-44.
10. Ezzell GA, Burmeister JW, Dogan N, et al. IMRT com-
missioning: multiple institution planning and dosimetry 
comparisons, a report from AAPM Task Group 119. Med 
Phys. 2009;36(11):5359-73.
11. Blanck O, Masi L, Damme MC, et al. Film-based delivery 
quality assurance for robotic radiosurgery: Commission-
ing and validation. Phys Med. 2015;31(5):476-83.
12. Lin MH, Veltchev I, Koren S, Ma C, Li J. Robotic radiosur-
gery system patient-specific QA for extracranial treat-
ments using the planar ion chamber array and the cylin-
drical diode array. J Appl Clin Med Phys. 2015;16(4):290-
305.
13. Kim J, Park K, Yoon J, et al. Feasibility Study of a Custom-
made Film for End-to-End Quality Assurance Test of Ro-
botic Intensity Modulated Radiation Therapy System. Prog 
Med Phys. 2016;27(4):189-95.
